MG
Therapeutic Areas
Almirall Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ebglyss/Lebrikizumab | Moderate-to-Severe Atopic Dermatitis | Marketed/Registration |
| Klisyri (tirbanibulin) | Actinic Keratosis | Marketed |
| Wynzora | Plaque Psoriasis | Marketed |
| Seysara (sarecycline) | Moderate-to-Severe Acne Vulgaris | Marketed |
| IL-1RAP Inhibitor (ALM22307) | Inflammatory Skin Diseases (e.g., Hidradenitis Suppurativa) | Preclinical |